In Vivo Gene Therapy for Canine SCID-X1 Using Cocal-Pseudotyped Lentiviral Vector-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In Vivo Gene Therapy for Canine SCID-X1 Using Cocal-Pseudotyped Lentiviral Vector

Published:2021-01-01 Issue:1-2 Volume:32 Page:113-127
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Rajawat Yogendra S.¹²,Humbert Olivier¹²,Cook Savannah M.¹²,Radtke Stefan¹²,Pande Dnyanada¹²,Enstrom Mark¹²,Wohlfahrt Martin E.¹²,Kiem Hans-Peter¹²³

Affiliation:

1. Stem Cell and Gene Therapy Program, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

2. Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.

3. Pathology, University of Washington School of Medicine, Seattle, Washington, USA.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/hum.2020.127

Reference62 articles.

1. Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans

2. The γc Family of Cytokines: Basic Biology to Therapeutic Ramifications

3. Molecular Defects in Human Severe Combined Immunodeficiency and Approaches to Immune Reconstitution

4. Treatment of infants identified as having severe combined immunodeficiency by means of newborn screening

5. Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vivo CAR T-cell generation in nonhuman primates using lentiviral vectors displaying a multidomain fusion ligand;Blood;2024-08-29

2. CD90-targeted lentiviral vectors for HSC gene therapy;Molecular Therapy;2023-10

3. Gene knock-outs in human CD34+ hematopoietic stem and progenitor cells and in the human immune system of mice;PLOS ONE;2023-06-28

4. Preclinical proof of concept for VivoVec, a lentiviral-based platform for in vivo CAR T-cell engineering;Journal for ImmunoTherapy of Cancer;2023-03

5. In Vivo Hematopoietic Stem Cell Genome Editing: Perspectives and Limitations;Genes;2022-11-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3